MYOACT total | β | 95% CI | P-value |
---|---|---|---|
Extramuscular activity in MYOACT | 0.475 | 0.438–0.511 | < 0.001 |
Physician global activity | 0.469 | 0.432–0.5007 | < 0.001 |
MMT-8 | −0.045 | −0.056 to −0.034 | < 0.001 |
MYOACT muscular (0–10) | 0.449 | 0.409–0.489 | < 0.001 |
Patient global activity (0–10) | 0.353 | 0.313–0.394 | < 0.001 |
Creatine phosphokinase (U/L) | 0.0002 | 4.51e-05–0.000314 | 0.009 |
Health Assessment Questionnaire (0–3) | 0.845 | 0.688–1.002 | < 0.001 |
Myositis Damage Index (0–10) | 0.378 | 0.332–0.424 | < 0.001 |
Physician global damage (0–10) | 0.347 | 0.297–0.396 | < 0.001 |
Patient global damage (0–10) | 0.230 | 0.185–0.274 | < 0.001 |
SF-12 physical domain score (0–100) | −0.046 | −0.055 to −0.036 | < 0.001 |
SF-12 mental domain score (0–100) | −0.018 | −0.028 to −0.008 | < 0.001 |
Prevalent group | −0.666 | −0.966 to −0.365 | < 0.001 |
Antisynthetase AAb group | −0.319 | −0.588 to −0.050 | 0.020 |